Search results
Colorectal cancer: How Metformin could help slow cancer cell growth
Medical News Today· 1 day agoUsing several different techniques to analyze the drug’s effects on the cells’ RNA, they found that...
Is Eli Lilly Stock A Buy After FDA Advisors Back Its Alzheimer's Drug?
Investor's Business Daily· 4 days agoTrulicity had $1.46 billion in first-quarter sales, down 26% and below the $1.63 billion Street...
These 3 Clinical-Stage Biotech Stocks Can Offer Exponential Gains | Investing.com NG
Investing.com· 23 hours agoShares Analysis by The Tokenist (Timothy Fries) covering: Pfizer Inc, Ocuphire Pharma Inc, Rocket...
Massive surge in pre-diabetes as high blood sugar levels create timebomb
Daily Express· 3 days agoA record 3.6million people are at high risk of developing diabetes as the nation battles an obesity...
Here's Why Eli Lilly Will Likely Announce a Stock Split
247wallst.com· 4 days agoWith its stock price fast approaching $1000 per share, drugmaker Eli lilly is poised for a forward...
Is Eli Lilly the Best Pharmaceutical Stock for You?
Motley Fool via Yahoo Finance· 3 days agoAs for the current products, they both are essentially the same drug: tirzepatide. But regulators approved the compound under the name Mounjaro in 2022...
Benefits of Sulforaphane: A Compound Found in Broccoli and Other Vegetables
Health via Yahoo News· 3 days agoRemember that supplements are minimally regulated by the Food and Drug Administration (FDA) and can...
Eli Lilly Runs Up 49% With Expectations For Weight-Loss Sales To Triple
Investor's Business Daily· 3 days agoRevenue from Eli Lilly's weight-loss drug is expected to triple over the next five years to over $50...
10 Reasons to Buy Eli Lilly Stock Now
247wallst.com· 1 day agoThe pharmaceutical sector is one that has gone from decades of heavy investment, high growth, and consolidation to a maturing space with a few key...
Meet The International Megacaps That 'Match Or Surpass' Magnificent Seven Stocks
Investor's Business Daily· 5 days agoDenmark-based Novo Nordisk offers GLP-1 diabetes and obesity drugs, a fast-growing market. It enjoys...